business2 months ago
GSK Acquires IDRx for $1.15 Billion to Boost Cancer Portfolio
GSK, the UK-based pharmaceutical giant, has announced that it has entered into an agreement to acquire the privately held biotechnology company IDRx. As per the terms...
